Abstract:Background To characterize the microbiome in early-onset colorectal cancer (aged <50, EOCRC) and late-onset CRC (aged ≥50, LOCRC) patients. Methods 460 CRC patients (167 EOCRC) were recruited in Guangzhou, and deep shotgun metagenomic sequencing was applied to stool and saliva samples. De novo genome assembly, binning, inStrain, StrainPhlAn and MetaPhlAn analyses were performed. Stool metagenomes from a Fudan study (Yang et al., 2021) consisting of 50 EOCRC, 50 LOCRC and 100 age-matched controls were also included. Results Despite age being a determining factor for the gut microbiome, our analyses found limited associations between the gut microbiome and age in CRC. Well-known CRC-associated taxa (IDDF2024-ABS-0170 Figure 1. CRC-associated taxa and genes enriched in both EOCRC and LOCRC (a)) and genes (IDDF2024-ABS-0170 Figure 1. CRC-associated taxa and genes enriched in both EOCRC and LOCRC (b)) were consistently enriched in both EOCRC and LOCRC. In the strain-level analysis on Fusobacterium nucleatum (Fn), we identified two Fn subspecies animalis Clades (Fna C1 and C2), with Fna C2 as the dominant strain (IDDF2024-ABS-0170 Figure 2. Distribution of Fna C1 and Fna C2 in CRC patients (a)). This observation is in line with a Nature study (Zepeda-Rivera et al., 2024). We confirmed that fadA abundance did not differ in patients carrying either Fna C1 or C2 (IDDF2024-ABS-0170 Figure 2. Distribution of Fna C1 and Fna C2 in CRC patients (b)). More importantly, we found that both the abundances of Fna C1 and C2 were associated with mismatch repair and HER2 expression status (IDDF2024-ABS-0170 Figure 2. Distribution of Fna C1 and Fna C2 in CRC patients (c,d)), suggesting their potential roles in CRC clinical outcomes. We identified two distinct Bacteroides fragilis (Bf) strain clusters with high genome-wide similarity to the reference genomes of strain NCTC 9343 and Q1F2 respectively (IDDF2024-ABS-0170 Figure 3. Two distinct Bf strain clusters in CRC patients (a)). Intriguingly, the abundance and prevalence of Bf toxin gene bft were significantly higher in patients with strain NCTC9343 than Q1F2 (IDDF2024-ABS-0170 Figure 3. Two distinct Bf strain clusters in CRC patients (b)). Only one strain cluster was identified for Escherichia coli (Ec) (IDDF2024-ABS-0170 Figure 4. Correlations between Ec and pks genomic island (a)). A positive correlation between pks genomic island and Ec was observed in the Guangzhou cohort, but no correlation in the Fudan cohort, indicating population heterogeneity. Lastly, we found that the baseline compositions of gut and oral microbiome had remarkable differences between patients with different responses in anti-PD1 treatment (IDDF2024-ABS-0170 Figure 5. Gut and oral microbes associated with anti-PD1 treatment response). Conclusions Our results highlight striking similarities in microbial signatures between EOCRC and LOCRC, emphasizing the important roles of microbiome in CRC biology and treatment.

Taxonomic and functional profiling of fecal metagenomes for the early detection of colorectal cancer

Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer

Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer

Identification of Microbial Markers Across Populations in Early Detection of Colorectal Cancer

Microbiome analysis reveals universal diagnostic biomarkers for colorectal cancer across populations and technologies

Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer

Untargeted GC-MS-Based Metabolomics for Early Detection of Colorectal Cancer

Leveraging Fecal Bacterial Survey Data to Predict Colorectal Tumors

Circulating Bacterial DNA As a Tool Towards Noninvasive Biomarkers for Colorectal Adenocarcinoma and Adenoma.

Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer

A multiple-dimension model for microbiota of patients with colorectal cancer from normal participants and other intestinal disorders

Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients

IDDF2021-ABS-0210 Altered Gut Metabolites and Bacterial Interactions Are Implicated in Colorectal Carcinogenesis and Can Detect Precancerous and Cancerous Lesions

Integrated analysis of colorectal neoplasia tissue and gut microbiome associated serum metabolites for diagnosis of early-stage CRC and advanced adenoma.

Elucidating the Gut Microbiome of Colorectal Cancer: 40 Fecal Bacteria as Non-invasive Biomarkers

Establishing High-Accuracy Biomarkers For Colorectal Cancer By Comparing Fecal Microbiomes In Patients With Healthy Families

Colorectal cancer-specific microbiome in peripheral circulation and cancer tissues

Progress of gut microbiome and its metabolomics in early screening of colorectal cancer

Distinct urinary metabolic profile of human colorectal cancer.

IDDF2024-ABS-0170 Metagenomic Analyses Highlight Strain-Level, Age-Independent and Immunotherapy-Associated Microbial Signatures in Colorectal Cancer

Profiling the metabolic disorder and detection of colorectal cancer based on targeted amino acids metabolomics